Wegovy™ Injection Effective Way For Weight Loss
Lifetsyle's MedSpa , Premium Aesthetics Range by Lifestyle Physicians

Lifestyle Physicians is committed to providing the highest quality of care and ensuring the safety of our patients, employees, providers, volunteers and visitors. We continue to monitor the evolving situation with COVID-19 on a daily basis and are taking the necessary steps to ensure we provide a safe environment of care for patients, in accordance with guidance from the Centers for Disease Control and Prevention (CDC) and in partnership with our local and state health departments.

Masks Required at All Times

  • You must wear a mask inside our clinic. We can provide a mask if you need it.
  • Covid symptoms? Patients should call the clinic before coming.

Obesity Medicine Clinic : The Caring Weight Loss Center in Warrenton

 The new wonder drug for weight loss:

Last year the FDA approved WEGOVYTM injection for weight loss . This has been a game changer for the majority of patients and we are seeing excellent results with the use of Wegovy™. Ozempic is the same medication as Wegovy™ and has been used for the treatment of type 2 diabetes mellitus for many years.


Semaglutide was developed in 2012, by a team of researchers at Novo Nordisk as a longer-acting alternative to liraglutide as a once-weekly diabetes therapy. It was given the brand name Ozempic. Clinical trials were started on 6 January 2016, and completed on 19 May 2017. It was FDA approved in December 2017 for the treatment of type 2 Diabetes. It was observed that patients were losing a significant amount of weight on this drug.A new trial was done in patients without dm2 to observe weight loss. The results showed that patients on semaglutide lost an average of 20 % of their weightwwf rolex datejust mens rolex calibre 2836 2813 116200sso automatic silver floral dial.

What is Wegovy™?

Wegovy™ (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist which is used along with diet and exercise for chronic weight management in adult patients who are overweight (BMI ≥27 kg/m2) or obese (BMI ≥30 kg/m2).

How does Wegovy™ (semaglutide ) work ?

Wegovy™ works by decreasing food intake by activating GLP-1 receptors. These receptors are present in many areas of the brain and are involved in appetite regulation. It increases the production of insulin, a hormone that lowers the blood sugar level. It appears to increase the growth of β cells in the pancreas, which are the sites of insulin production.

It inhibits the production of glucagon, which is a hormone that increases blood sugar. It slows down digestion in the stomach resulting in a feeling of fullness.

Wegovy- weight loss injection

How is Wegovy™ used?

Wegovy™ is administered by subcutaneous injection once weekly, with or without meals. It can given anywhere in the belly.

Who cannot use Wegovy™ injection for weight loss? Anyone with a history of medullary thyroid cancer or pancreatitis should not use Wegovy™.

What are the side effects of WegovyTM ?

The most common side effects of Wegovy™ injection include nausea, diarrhea, vomiting, constipation, stomach pain, headache,fatigue, upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn.

How can I deal with that?

The doctor can prescribe you nausea medication. Your body generally adapts and as you continue to use the medicine, these side effects will decrease.

What are the other serious side effects?

Inflammation of your pancreas (pancreatitis). if you have severe pain in your stomach area (abdomen) that will not go away, with or without vomiting this may mean you have pancreatitis gallbladder problems. Wegovy™ may cause gallbladder problems, including gallstones.

Increased risk of low blood sugar (hypoglycemia) in patients with type 2 diabetes, especially those who also take medicines for type 2 diabetes such as sulfonylureas or insulin.

Remember, this is not a complete list of side effects. This is just basic information for you to get started. Please talk to your doctor for further information.


In May 2022, the FDA approved tirzepatide (Mounjaro) for the treatment of Type 2 diabetes in adults. Tirzepatide’s FDA approval marks the first in a new class of diabetes medications: a dual GIP/GLP-1 receptor agonist. It also causes significant weight loss but is currently not yet approved for weight lossproducthermes 17383 fashion casual shoes.

Other medications we prescribe:

  • Phentermine
  • Bontril
  • contrave
  • Saxenda
  • Qysmia
  • Plenity
Book an Appointment Call Us



Call Us

    Disclaimer !

    All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease. *Results may vary